Swiss Life Asset Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.81M Sell
92,324
-14,491
-14% -$1.39M 0.04% 347
2026
Q1
$11.1M Buy
106,815
+9,345
+10% +$1.06M 0.05% 252
2025
Q4
$9.83M Buy
97,470
+11,044
+13% +$1.2M 0.05% 270
2025
Q3
$10.7M Buy
86,426
+59,533
+221% +$7.39M 0.06% 259
2025
Q2
$3.23M Sell
26,893
-42,803
-61% -$5.71M 0.02% 469
2025
Q1
$10.3M Buy
69,696
+2,716
+4% +$415K 0.07% 204
2024
Q4
$10.9M Buy
66,980
+7,598
+13% +$1.24M 0.08% 185
2024
Q3
$9.67M Sell
59,382
-655
-1% -$97.1K 0.11% 176
2024
Q2
$8.19M Buy
60,037
+53,313
+793% +$7.4M 0.1% 183
2024
Q1
$1.03M Sell
6,724
-3,766
-36% -$562K 0.01% 412
2023
Q4
$1.5M Buy
10,490
+5,379
+105% +$717K 0.02% 457
2023
Q3
$669K Sell
5,111
-54,760
-91% -$8.32M 0.01% 566
2023
Q2
$9.52M Buy
59,871
+27,587
+85% +$4.45M 0.14% 185
2023
Q1
$5.11M Buy
32,284
+9,022
+39% +$1.35M 0.08% 305
2022
Q4
$3.27M Buy
23,262
+4,347
+23% +$617K 0.05% 357
2022
Q3
$2.43M Sell
18,915
-6,146
-25% -$887K 0.04% 409
2022
Q2
$3.54M Buy
25,061
+2,934
+13% +$419K 0.06% 350
2022
Q1
$3.07M Buy
22,127
+840
+4% +$129K 0.04% 371
2021
Q4
$3.71M Sell
21,287
-30,206
-59% -$5.04M 0.05% 363
2021
Q3
$8.52M Buy
51,493
+13,970
+37% +$2.41M 0.12% 200
2021
Q2
$3.59M Sell
37,523
-4,164
-10% -$760K 0.04% 377
2021
Q1
$8.04M Sell
41,687
-1,962
-4% -$378K 0.12% 216
2020
Q4
$8.81M Sell
43,649
-77,290
-64% -$16M 0.13% 188
2020
Q3
$25.4M Sell
120,939
-11,640
-9% -$2.59M 0.38% 59
2020
Q2
$29.1M Buy
132,579
+6,153
+5% +$1.23M 0.47% 48
2020
Q1
$21.9M Sell
126,426
-2,316
-2% -$383K 0.42% 53
2019
Q4
$19.8M Sell
128,742
-71,287
-36% -$10.7M 0.37% 65
2019
Q3
$30.4M Sell
200,029
-4,556
-2% -$720K 0.4% 67
2019
Q2
$31.3M Sell
204,585
-257
-0.1% -$39.3K 0.38% 74
2019
Q1
$32.9M Buy
204,842
+43,368
+27% +$6.73M 0.42% 65
2018
Q4
$24.9M Buy
161,474
+7,300
+5% +$1.14M 0.51% 59
2018
Q3
$23.2M Sell
154,174
-41,941
-21% -$5.96M 0.31% 90
2018
Q2
$26.5M Buy
196,115
+58,784
+43% +$7.26M 0.4% 70
2018
Q1
$18.3M Buy
137,331
+94,970
+224% +$12.8M 0.32% 91
2017
Q4
$6.3M Buy
42,361
+6,511
+18% +$886K 0.14% 109
2017
Q3
$4.72M Buy
+35,850
New +$4.82M 0.13% 122
2017
Q2
Sell
-2,867
Closed -$387K 459
2017
Q1
$387K Sell
2,867
-10,697
-79% -$1.39M 0.01% 410
2016
Q4
$1.63M Buy
13,564
+828
+7% +$97.6K 0.05% 186
2016
Q3
$1.59M Buy
12,736
+3,921
+44% +$514K 0.05% 176
2016
Q2
$1.22M Buy
8,815
+7,149
+429% +$927K 0.05% 160
2016
Q1
$210K Sell
1,666
-8,877
-84% -$1.13M 0.01% 343
2015
Q4
$1.34M Buy
10,543
+5,431
+106% +$674K 0.06% 127
2015
Q3
$591K Sell
5,112
-26,561
-84% -$2.98M 0.03% 190
2015
Q2
$3.3M Sell
31,673
-3,354
-10% -$362K 0.12% 101
2015
Q1
$3.86M Buy
+35,027
New +$3.8M 0.16% 100

Other funds holding CLX

Swiss Life Asset Management's CLX Position: Q2 2026 in Review

Swiss Life Asset Management reduced its Clorox (CLX) stake by 14% in Q2 2026, selling an estimated $1.39M and leaving 92,324 shares worth $8.81M. The position accounts for 0.04% of the portfolio, ranked #347.

Swiss Life Asset Management first reported a position in CLX in Q1 2015 and has held it in 45 quarters since. The position peaked at $32.9M in Q1 2019. 748 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Swiss Life Asset Management held 92,324 shares of Clorox worth $8.81M as of Q2 2026.
  • Swiss Life Asset Management sold 14,491 Clorox shares in Q2 2026, an estimated $1.39M.
  • Clorox made up 0.04% of Swiss Life Asset Management's portfolio in Q2 2026, its #347 holding.
  • Swiss Life Asset Management first reported a position in Clorox in Q1 2015 and has held it in 45 quarters since.
  • Swiss Life Asset Management's Clorox position peaked at $32.9M in Q1 2019.
  • 748 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.